Regulatory Attitudes Toward Patient Communications

Regulatory Attitudes Toward Patient Communications

Download the Free White Paper

The proliferation of multinational clinical trials is creating a need for increased education and clarification surrounding ethics committees and their review systems. BBK Worldwide surveyed a host of ethics committee members in an effort to hone in on global regulatory attitudes toward communicating directly to patients about clinical trials in order to improve the ways we approach and engage with them through study materials and outreach.